200 related articles for article (PubMed ID: 22483732)
21. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.
Almawi WY; Keleshian SH; Borgi L; Fawaz NA; Abboud N; Mtiraoui N; Mahjoub T
J Thromb Thrombolysis; 2005 Dec; 20(3):163-8. PubMed ID: 16261289
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptives and the risk of myocardial infarction.
Tanis BC; van den Bosch MA; Kemmeren JM; Cats VM; Helmerhorst FM; Algra A; van der Graaf Y; Rosendaal FR
N Engl J Med; 2001 Dec; 345(25):1787-93. PubMed ID: 11752354
[TBL] [Abstract][Full Text] [Related]
25. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
[TBL] [Abstract][Full Text] [Related]
26. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
27. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
[TBL] [Abstract][Full Text] [Related]
28. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A.
Doggen CJ; Cats VM; Bertina RM; Rosendaal FR
Circulation; 1998 Mar; 97(11):1037-41. PubMed ID: 9531249
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
30. Haemostatic gene polymorphisms in young indian asian subjects with acute myocardial infarction.
Ranjith N; Pegoraro RJ; Rom L
Med Sci Monit; 2003 Oct; 9(10):CR417-21. PubMed ID: 14523329
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
[TBL] [Abstract][Full Text] [Related]
32. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction.
Van de Water NS; French JK; Lund M; Hyde TA; White HD; Browett PJ
J Am Coll Cardiol; 2000 Sep; 36(3):717-22. PubMed ID: 10987590
[TBL] [Abstract][Full Text] [Related]
34. Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.
Weger M; Renner W; Pinter O; Stanger O; Temmel W; Fellner P; Schmut O; Haas A
Eye (Lond); 2003 Aug; 17(6):731-4. PubMed ID: 12928685
[TBL] [Abstract][Full Text] [Related]
35. [Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].
Palomo I; Pereira J; Alarcón M; Pinochet C; Vélez MT; Hidalgo P; Skagerberg K; Poblete F
Rev Med Chil; 2005 Dec; 133(12):1425-33. PubMed ID: 16446869
[TBL] [Abstract][Full Text] [Related]
36. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
37. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
38. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
39. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
[TBL] [Abstract][Full Text] [Related]
40. Genetic risk factors in myocardial infarction at young age.
Incalcaterra E; Hoffmann E; Averna MR; Caimi G
Minerva Cardioangiol; 2004 Aug; 52(4):287-312. PubMed ID: 15284679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
